title: Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system.
authors.forename: P G
authors.initials: PG
authors.lastname: Lindqvist
authors.forename: J
authors.initials: J
authors.lastname: Rosing
authors.forename: A
authors.initials: A
authors.lastname: Malmquist
authors.forename: A
authors.initials: A
authors.lastname: Hillarp
mesh_terms: D000328:Adult; D001780:Blood Coagulation Tests; D003271:Contraceptive Agents, Female / Q000009:adverse effects; D017135:Desogestrel / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D045167:Progesterone Congeners / Q000009:adverse effects; D019851:Thrombophilia / Q000209:etiology*
chemical_list: D003271:Contraceptive Agents, Female; D045167:Progesterone Congeners; C044815:etonogestrel; D017135:Desogestrel